Cargando…

Melatonin Inhibits hIAPP Oligomerization by Preventing β-Sheet and Hydrogen Bond Formation of the Amyloidogenic Region Revealed by Replica-Exchange Molecular Dynamics Simulation

The pathogenesis of type 2 diabetes (T2D) is highly related to the abnormal self-assembly of the human islet amyloid polypeptide (hIAPP) into amyloid aggregates. To inhibit hIAPP aggregation is considered a promising therapeutic strategy for T2D treatment. Melatonin (Mel) was reported to effectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Zhu, Xinyi, Song, Xiaona, Zhang, Qingwen, Qian, Zhenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499688/ https://www.ncbi.nlm.nih.gov/pubmed/36142176 http://dx.doi.org/10.3390/ijms231810264

Ejemplares similares

Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation
por: Mo, Yuxiang, et al.
Publicado: (2016)

Site-specific single point mutation by anthranilic acid in hIAPP(8–37) enhances anti-amyloidogenic activity
por: Kalita, Sourav, et al.
Publicado: (2021)

Effect of DNA Origami Nanostructures on hIAPP Aggregation
por: Hanke, Marcel, et al.
Publicado: (2020)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity
por: Krotee, Pascal, et al.
Publicado: (2017)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20–29)
por: Hajiraissi, Roozbeh, et al.
Publicado: (2019)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
por: Sevcuka, Adriana, et al.
Publicado: (2022)

Modulation of the Conformational Space of SARS‐CoV‐2 RNA Quadruplex RG‐1 by Cellular Components and the Amyloidogenic Peptides α‐Synuclein and hIAPP
por: Mukherjee, Sanjib K., et al.
Publicado: (2022)

Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate
por: Rodriguez Camargo, Diana C, et al.
Publicado: (2017)

Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
por: Hernández, Miriam García, et al.
Publicado: (2018)

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2017)

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
por: Xu, Yong, et al.
Publicado: (2022)

Nanoscale Surface Topography Modulates hIAPP Aggregation Pathways at Solid–Liquid Interfaces
por: Hanke, Marcel, et al.
Publicado: (2021)

The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM
por: Meleleo, Daniela, et al.
Publicado: (2023)

Site-specific detection of protein secondary structure using 2D IR dihedral indexing: a proposed assembly mechanism of oligomeric hIAPP
por: Maj, Michał, et al.
Publicado: (2017)

Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus
por: Altamirano-Bustamante, Myriam M., et al.
Publicado: (2019)

Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization
por: Mishra, Aseem, et al.
Publicado: (2013)

A Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP
por: Shi, Yue, et al.
Publicado: (2019)

β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
por: Lesma, Jacopo, et al.
Publicado: (2021)

Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
por: Hassan, Shahab, et al.
Publicado: (2022)

Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation
por: Jia, Yan, et al.
Publicado: (2013)

Diabetes Drug Discovery: hIAPP(1–37) Polymorphic Amyloid Structures as Novel Therapeutic Targets
por: Fernández-Gómez, Isaac, et al.
Publicado: (2018)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
por: Meng, Qin-Yu, et al.
Publicado: (2020)

Metastable intermediate during hIAPP aggregation catalyzed by membranes as detected with 2D IR spectroscopy
por: Dicke, Sidney S., et al.
Publicado: (2022)

Active Immunization Against hIAPP Oligomers Ameliorates the Diabetes- Associated Phenotype in a Transgenic Mice Model
por: Bram, Yaron, et al.
Publicado: (2017)

High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice
por: Xi, Xiao-Xia, et al.
Publicado: (2019)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice
por: Franko, Andras, et al.
Publicado: (2018)

Pentapeptide Protects INS-1 Cells From hIAPP-Mediated Apoptosis by Enhancing Autophagy Through mTOR Pathway
por: Lin, Jianzhen, et al.
Publicado: (2019)

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity
por: Paul, Ashim, et al.
Publicado: (2020)

Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes
por: Altamirano-Bustamante, Nelly F., et al.
Publicado: (2020)

Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP(1–37)) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation
por: Wang, Qianqian, et al.
Publicado: (2014)

Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus
por: Höppener, J. W. M., et al.
Publicado: (2008)

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer
por: Kim, Jinyoung, et al.
Publicado: (2021)

Structural Similarities and Differences between Amyloidogenic and Non-Amyloidogenic Islet Amyloid Polypeptide (IAPP) Sequences and Implications for the Dual Physiological and Pathological Activities of These Peptides
por: Wu, Chun, et al.
Publicado: (2013)

Mechanistic Insights into the Polymorphic Associations and Cross-Seeding of Aβ and hIAPP in the Presence of Histidine Tautomerism: An All-Atom Molecular Dynamic Study
por: Salimi, Abbas, et al.
Publicado: (2022)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes (Adv. Sci. 34/2022)
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model
por: Yeo, Hyeon Ji, et al.
Publicado: (2023)

Oligomerization of Human Cystatin C—An Amyloidogenic Protein: An Analysis of Small Oligomeric Subspecies
por: Wojciechowska, Daria, et al.
Publicado: (2022)

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
por: Frangolho, Ana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d6gg1u3ck94sfa1dedq98m3o53